Navigation Links
Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU
Date:1/13/2010

The vaccine is administered as nasal spray instead of being injected. It is produced in cultured cells (Vero cells). This process permits automated production in bioreactors and can easily be scaled in line with the respective demand.

"Our new generation of live attenuated vaccines offers optimized effectiveness and combines high safety and maximum efficiency," explains Andrej Egorov, Vice President Research at AVIR Green Hills and one of the leading experts on live attenuated influenza vaccines.

Plans for the future

In 2010, AVIR Green Hills Biotechnology plans to run another clinical phase II study in Vienna to test the seasonal vaccine H1N1 in persons above age 65. Other studies in the pipeline are those for a monovalent H3N2 and B vaccine, which will be followed by a study for the trivalent vaccine H1N1, H3N2 and B.

In the first quarter of 2010, AVIR Green Hills Biotechnology expects to have the data from the completed phase I study for the pandemic H5N1 vaccine deltaFLU, which was also carried out at the Department of Clinical Pharmacology at the Vienna General Hospital.

AVIR Green Hills Biotechnology AG

AVIR Green Hills Biotechnology is a biopharmaceutical company based in Vienna, Austria. It was founded in 2002 and currently has a staff of 50 employees. The company's core competence is the development of innovative vaccines against viral infections and cancer.

The deltaFLU development is supported by two research projects funded by the European Union in the 6th framework program (projects FLUVACC and Intranasal H5 Vaccine). These projects led by AVIR Green Hills Biotechnology combine expertise of a renowned international consortium comprising national and international research partners.

    Contact: Isolde Bergmann

'/>"/>
SOURCE AVIR Green Hills Biotechnology AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
2. JumpStart Invests in Checkpoint Surgical
3. Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity
4. Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
5. Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
6. AMT Starts Development LPLChip(TM) With Progenika
7. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
8. Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
9. R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
11. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... resignation of Mr. Fuxiang Zhang as the ... Ms. Rebecca Yingnan Zhang has been appointed ... directors, effective immediately. Meanwhile, Ms. Zhang resigned from the ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "Arthroscopy ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose ... size the world market for Arthroscopy Devices. ... trends impacting the market for these products. ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... KARLSRUHE, Germany, and CHICAGO, November 1, 2011 ... a comprehensive product offering for endoscopic spinal surgery, ... new Multiuse-Set includes instruments for endoscopic facet joint ... iLESSYS® system for 360° decompression, launched in spring ...
... ALLEGAN, Mich., Nov. 1, 2011 Perrigo Company ... Pharmaceuticals, received final approval for Epinastine HCl ophthalmic ... will commence shipment of the product immediately. ... epinastine that is indicated for the prevention of ...
Cached Medicine Technology:joimax® Launches Numerous Innovations at NASS Chicago From November 2 - 4, 2011 2Perrigo Announces Launch of Generic Version of Elestat® 2
(Date:5/23/2015)... May 23, 2015 Injury lawyer Steven H. ... been passed by the Maryland legislature but which has not ... General Assembly passed HB 449 with overwhelming bipartisan ... not signed it into law. This bill ensures that fracking ... growing that demonstrates the danger of fracking to our water ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The American ... exciting events in June. They will hold a webinar ... and a two-day class on Classical Chinese Medicine. , ... 3, Dr. Steve Given, the Dean of Clinical Education, ... the new First Professional Doctorate program. ACTCM is currently ...
(Date:5/22/2015)... May 22, 2015 Hundreds of ... behalf of individuals who allegedly experienced serious internal ... continue to move forward in the U.S. District ... Pretrial Order dated May 4, 2015, the Court ... and electronically stored information. Among other things, the ...
(Date:5/22/2015)... May 22, 2015 Combination therapy, ... option for chronic obstructive pulmonary disorder (COPD) as ... and AstraZeneca plc as well as Germany’s Boehringer ... and position. But will market payers, clinicians and ... well-entrenched products to completely new ones? , In ...
(Date:5/22/2015)... 2015 Family, friends, students, colleagues, mentors ... oncologist, Dr. LaSalle D. Leffall, on Monday, May 18, ... after Grand Rounds in the hospital’s Tower Auditorium. Leffall’s ... the auditorium, trying to keep the secret. “I’d like ... sees me, he’ll know something is up,” she said. ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... ... Reduction argues that e-cigarettes carry around one percent of the risk of electronic cigarettes and ... ... with E Cigarette Direct Professor Carl Phillips, associate professor at the University of ...
... as Best Online Health Brand , VISITS HIT NEW ... 28 dLife, the #1 web site serving the diabetes community, ... all time high with 1.1 million total visits*. The November ... 2008 in visits and page views. , "Millions of people with ...
... , ... Hailed by best selling authors such as Jack Canfield, Dr. ... sought after fitness guru to date, who entertains, educates and enlightens audiences ... Jennifer Nicole Lee (JNL) is a weight loss success story who has ...
... Inaugural ... , ... (PRWEB) December 28, 2009 -- The Anapol Schwartz Foundation, established by law firm Anapol, ... award will honor an inspiring individual who has enhanced the lives of burn survivors ...
... 27 Double check what was said by Lori Robertson, managing ... head, especially when she purports to know the contents of federal ... be believed. , Robertson admits that she does ... in analyzing legislation beyond her BA in advertising. What she ...
... day to help prevent chapping, experts advise , SATURDAY, ... chilly and low on humidity, and the air inside is ... and cracked lips, dermatologists say. , To prevent scaling, flaking ... cold months by applying a cream-based moisturizer every day, recommends ...
Cached Medicine News:Health News:Professor: No Doubt Electronic Cigarettes Safer than Cigarettes 2Health News:dLife.com Hits 1 Million Plus Visitors! 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 3Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 4Health News:The Anapol Schwartz Foundation Announces Anapol Advocate Award 2Health News:Big Whoppers of 2009 from FactCheck.org 2Health News:Skin Needs Protection From Winter Weather 2
Hardy pituitary spoon, bayonet, malleable....
Cushing pituitary spoons, malleable copper, silver plated....
... on the T.L.I.F. market as the premium banana-shaped ... clinical history and the amazing success of the ... sure to be king of the jungle amongst ... mm in height. The footprint is 28 mm ...
... Implant system. Material that has a modulus ... The result is an implant that meets ... while optimizing the fusion environment through an ... design with 5 and 10 degrees of ...
Medicine Products: